Farther Finance Advisors’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Farther Finance Advisors’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$263K	Buy	3,970 +2	+0.1%	+$117	﹤0.01%	2040
2026 Q1	$217K	Buy	+3,968	New	+$221K	﹤0.01%	1963

Other funds holding XPH

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

KWM

Kingsview Wealth Management Grants Pass, Oregon $8.25B AUM 24.8% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

FCBT

First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return

Envestnet Portfolio Solutions Chicago, Illinois $20.9B AUM 19.34% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Evelyn Partners London $46.9B AUM

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Farther Finance Advisors's XPH Position: Q2 2026 in Review

Farther Finance Advisors increased its State Street SPDR S&P Pharmaceuticals ETF (XPH) stake by 0.05% in Q2 2026, buying an estimated $117 and bringing the position to 3,970 shares worth $263K. The position accounts for ﹤0.01% of the portfolio, ranked #2040.

Farther Finance Advisors first reported a position in XPH in Q1 2026 and has held it in 2 quarters since. 93 funds tracked by Wall St. Rank hold XPH as of Q2 2026.

Farther Finance Advisors held 3,970 shares of State Street SPDR S&P Pharmaceuticals ETF worth $263K as of Q2 2026.
Farther Finance Advisors bought 2 State Street SPDR S&P Pharmaceuticals ETF shares in Q2 2026, an estimated $117.
State Street SPDR S&P Pharmaceuticals ETF made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #2040 holding.
Farther Finance Advisors first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q1 2026 and has held it in 2 quarters since.
93 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.